» Articles » PMID: 34289653

Warfarin is Associated with the Risk of Vascular Calcification in Abdominal Aorta in Hemodialysis Patients: a Multicenter Case-control Study

Overview
Journal Turk J Med Sci
Specialty General Medicine
Date 2021 Jul 22
PMID 34289653
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vascular calcifications (VCs), recognized risk factor for increased mortality, are highly prevalent in hemodialysis (HD) patients. We aimed to investigate the relation between VC and warfarin use with plain radiography.

Methods: VCs were assessed using Adragao (radial and digital) and Kauppila (aortic) scores in 76 HD patients from six centers. Out of a total 711 HD patients, there were 32 (4.5%) who had been treated with warfarin for at least 1 year, and we included 44 control patients.

Results: Of the patients, 47% were females, the mean age was 66 ± 9 years, 23% were diabetics, the mean dialysis vintage was 68 ± 38 months. In warfarin group, median Kauppila score was higher than in control group [11 vs 6.5, (25%-75% percentile, 5 vs. 15), p = 0.032] and the percentage of the patients with a Kauppila score of >6 was higher, as well (76.6% vs. 50%; p = 0.029). Median Adragao score was not significantly different between the two groups [7 vs. 6, (%25,%75 percentile 6 vs. 8), p = 0.17]. Logistic regression analysis revealed that warfarin treatment was independently associated with Kauppila scores of >6 (OR 3.60, 95% CI 1.18-10.9, p = 0.024).

Discussion: In this study, we found that warfarin is associated to vascular calcifications, especially in aorta of HD patients.

Citing Articles

Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis.

Kosciuszek N, Kalta D, Singh M, Savinova O Front Cardiovasc Med. 2022; 9:938567.

PMID: 36061545 PMC: 9437425. DOI: 10.3389/fcvm.2022.938567.

References
1.
Kwon H, Lee O, Kim M, Joo W, Lee S, Kim M . The association between mortality and abdominal aortic calcification and relation between its progression and serum calcium concentration in chronic hemodialysis patients. Kidney Res Clin Pract. 2016; 33(2):95-102. PMC: 4714181. DOI: 10.1016/j.krcp.2014.04.003. View

2.
Schurgers L, Joosen I, Laufer E, Chatrou M, Herfs M, Winkens M . Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One. 2012; 7(8):e43229. PMC: 3430691. DOI: 10.1371/journal.pone.0043229. View

3.
Tsai C, Marcus L, Patel P, Battistella M . Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes. Can J Kidney Health Dis. 2017; 4:2054358117735532. PMC: 5652660. DOI: 10.1177/2054358117735532. View

4.
Rennenberg R, van Varik B, Schurgers L, Hamulyak K, Ten Cate H, Leiner T . Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans. Blood. 2010; 115(24):5121-3. DOI: 10.1182/blood-2010-01-264598. View

5.
Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman R, Block G . Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int. 2006; 70(9):1623-8. DOI: 10.1038/sj.ki.5001820. View